Securities code: 603990 securities abbreviation: Suzhou Medicalsystem Technology Co.Ltd(603990) Announcement No.: 2022-001 Suzhou Medicalsystem Technology Co.Ltd(603990)
Suspension announcement on planning change of control
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Suzhou Medicalsystem Technology Co.Ltd(603990) (hereinafter referred to as “the company”) recently received a notice from Mr. Weng Kang, the controlling shareholder of the company, and Ms. Yan huanghong and Mr. Wang Jianhua, who acted in concert. They are planning to change the controlling shareholder and actual controller of the company.
In view of the major uncertainties in the above matters, in order to ensure fair information disclosure, safeguard the interests of investors and avoid abnormal fluctuations in the company’s share price, in accordance with the stock listing rules of Shanghai Stock Exchange (revised in January 2022), the self regulatory guidelines for listed companies of Shanghai Stock Exchange No. 4 – suspension and resumption of trading and other relevant provisions, Upon the application of the company to Shanghai Stock Exchange, the trading of the company’s shares (securities code: 603990, securities abbreviation: Suzhou Medicalsystem Technology Co.Ltd(603990) ) will be suspended from the morning of the opening of the market on Thursday, January 13, 2022. It is expected that the suspension will not exceed two trading days.
During the suspension period, the company will perform the obligation of information disclosure in strict accordance with the provisions and requirements of relevant laws and regulations according to the progress of the matter. After the above matters are determined, the company will timely issue relevant announcements and apply for resumption of trading. The information disclosure media designated by the company are China Securities News, Shanghai Securities News and the website of Shanghai Stock Exchange (www.see. Com. CN), All information of the company shall be subject to the announcement published in the above designated media. Please pay attention to the follow-up announcement and pay attention to the investment risk. It is hereby announced.
Suzhou Medicalsystem Technology Co.Ltd(603990) board of directors January 13, 2022
